|
|
 |
|
Viewing report
|
|
|
|
Lou Gehrigs Disease - Global Strategic Business Report
Global Industry Analysts, Inc., April 2010, Pages: 258
This report analyzes the Global market for Lou Gehrigs Disease in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 37 companies including many key and niche players such as Aeolus Pharmaceuticals, Inc., Amorfix Life Sciences Ltd., Avicena Group, Inc., Ceregene, Inc., CytRx Corporation, Genzyme Corporation, Isis Pharmaceuticals, Inc., Knopp Neurosciences, Maas Biolab, NeuroNova AB, Sygnis Pharma AG, Teva Pharmaceutical Industries Ltd., and Trophos SA. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Huntingtons Disease Therapeutics - Global Strategic Business Report
Stem Cell Approaches in Neurology and Psychiatry 2010
Multiple Myeloma Therapeutics - Global Strategic Business Report
Alzheimers and Parkinsons Disease - Global Strategic Business Report
The Neurodevice 2012 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware
Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report
Competitor Analysis: Amyotrophic Lateral Sclerosis (ALS) / Lou Gehrig's Disease
Medical Waste Management - A US Market Report
Hepatitis C Virus and Therapeutics - Global Strategic Business Report
Narcolepsy Therapeutics - Global Strategic Business Report
|
|
|
|
